Clinical Trials
6 trialsNCT05113290 2022-01-27
Effect and Safety of Recombinant Human Adenovirus Type 5 in Advanced HCC With Stable Disease After Sorafenib Treatment
First Affiliated Hospital Xi'an Jiaotong University
Phase 4 Unknown
NCT04127396 2021-07-23
Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT
Beijing Ditan Hospital
Phase 4 Unknown
NCT02504983 2020-02-05
Clinical Trial for GALNT14 Genotype - Guided, Sorafenib in Combination With TACE in Hepatocellular Carcinoma
Chang Gung Memorial Hospital
Phase 4 Unknown
NCT02733809 2019-08-20
Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma
King Saud University
Phase 4 Unknown
NCT03518502 2018-05-08
Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis
Korea University
Phase 4 Unknown
NCT03178656 2017-12-21
A Trial to Compare Surgery With Sorafenib for Hepatic Celluler Cancer With Portal Vein Tumor Thrombosis
Huazhong University of Science and Technology
Phase 4 Unknown